Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 8, 2013 - Issue 3
Journal homepage
37
Views
0
CrossRef citations to date
0
Altmetric
Review

Multiple sclerosis and pregnancy

Elisa Picardo Department of Gynecology and Obstetrics, University of Turin, S. Anna Hospital, V. Ventimiglia 3, 10126 Turin, Italy. [email protected]
,
Emilie Marion Canuto Department of Gynecology and Obstetrics, University of Turin, S. Anna Hospital, V. Ventimiglia 3, 10126 Turin, Italy
,
Luca Marozio Department of Gynecology and Obstetrics, University of Turin, S. Anna Hospital, V. Ventimiglia 3, 10126 Turin, Italy
&
Chiara Benedetto Department of Gynecology and Obstetrics, University of Turin, S. Anna Hospital, V. Ventimiglia 3, 10126 Turin, Italy
Pages 223-234 | Published online: 10 Jan 2014

References

  • Compston A, Ebers G, Lassmann H et al. Multiple Sclerosis, McAlpine’s Multiple Sclerosis (3rd Edition). Churchill Livingstone, London, UK (1998).
  • Orton SM, Herrera BM, Yee IM et al.; Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5(11), 932–936 (2006).
  • Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can. J. Neurol. Sci. 20(1), 17–29 (1993).
  • Koutsouraki E, Costa V, Baloyann S. Epidemiology of multiple sclerosis in Europe: a review. Int. Rev. Psychiatr. 22(1), 2–13 (2010).
  • Noseworthy JH. Progress in determining the causes and treatment of multiple sclerosis. Nature 399(Suppl. 6738), A40–A47 (1999).
  • Riley C, Azevedo C, Bailey M, Pelletier D. Clinical applications of imaging disease burden in multiple sclerosis: MRI and advanced imaging techniques. Expert Rev. Neurother. 12(3), 323–333 (2012).
  • Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J. Neuroophthalmol. 31(4), 362–373 (2011).
  • Miller E. Multiple sclerosis advances in experimental medicine and biology. 724, 222–238 (2012).
  • Weinshenker BG, Bass B, Rice GP et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112(Pt 1), 133–146 (1989).
  • Winder G, Achiron A. [Benign multiple sclerosis]. Harefuah 150(5), 463–465 (2011).
  • Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 103(2), 281–300 (1980).
  • González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de León AC. Sex hormones and autoimmunity. Immunol. Lett. 133(1), 6–13 (2010).
  • Nussinovitch U, Shoenfeld Y. The role of gender and organ specific autoimmunity. Autoimmun. Rev. 11(6–7), A377–A385 (2012).
  • Zorgdrager A, De Keyser J. Menstrually related worsening of symptoms in multiple sclerosis. J. Neurol. Sci. 149(1), 95–97 (1997).
  • Wingerchuk DM, Rodriguez M. Premenstrual multiple sclerosis pseudoexacerbations: role of body temperature and prevention with aspirin. Arch. Neurol. 63(7), 1005–1008 (2006).
  • Hernán MA, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 55(6), 848–854 (2000).
  • Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult. Scler. 15(9), 1037–1042 (2009).
  • Cavalla P, Rovei V, Masera S et al. Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol. Sci. 27(4), 231–239 (2006).
  • Michel L, Foucher Y, Vukusic S et al.; Club Francophone de la Sclérose En Plaques (CFSEP). Increased risk of multiple sclerosis relapse after in vitro fertilisation. J. Neurol. Neurosurg. Psychiatr. 83(8), 796–802 (2012).
  • Hellwig K, Schimrigk S, Beste C, Muller T, Gold R. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur. Neurol. 61(2), 65–68 (2009).
  • Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat. Med. 8(12), 1421–1426 (2002).
  • Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur. J. Obstet. Gynecol. Reproduct. Biol. 115, 3–9 (2004).
  • van der Kop ML, Pearce MS, Dahlgren L et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann. Neurol. 70(1), 41–50 (2011).
  • Finkelsztejn A, Brooks JB, Paschoal FM Jr, Fragoso YD. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG 118(7), 790–797 (2011).
  • Poser S, Poser W. Multiple sclerosis and gestation. Neurology 33(11), 1422–1427 (1983).
  • Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118(Pt 1), 253–261 (1995).
  • Neuteboom RF, Janssens AC, Siepman TA et al. Pregnancy in multiple sclerosis: clinical and self-report scales. J. Neurol. 259(2), 311–317 (2012).
  • Vukusic S, Hutchinson M, Hours M et al.; Pregnancy In Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127(Pt 6), 1353–1360 (2004).
  • Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 339(5), 285–291 (1998).
  • Erkkilä H, Raitta C, Iivanainen M, Taskinen E, Unnérus HA, Gummerus M. Optic neuritis during lactation. Graefes Arch. Clin. Exp. Ophthalmol. 222(3), 134–138 (1985).
  • Retzloff MG, Kobylarz EJ, Eaton C. Optic neuritis with transient total blindness during lactation (1). Obstet. Gynecol. 98(5 Pt 2), 902–904 (2001).
  • Lorenzi AR, Ford HL. Multiple sclerosis and pregnancy. Postgrad. Med. J. 78(922), 460–464 (2002).
  • Payne D, McPherson KM. Becoming mothers. Multiple sclerosis and motherhood: a qualitative study. 32(8), 629–638 (2010).
  • Jalkanen A, Alanen A, Airas L; Finnish Multiple Sclerosis and Pregnancy Study Group. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult. Scler. 16(8), 950–955 (2010).
  • Lommers E, Lecrompe L, Moonen G, Phan-Ba R, Belachew S. Vitamin D tweets light to genes in multiple sclerosis. Rev. Med. Liege. 67(5–6), 359–365 (2012).
  • Mueller BA, Zhang J, Critchlow CW. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am. J. Obstet. Gynecol. 186(3), 446–452 (2002).
  • Bertero MT, Caligaris-Cappio F. Anemia of chronic disorders in systemic autoimmune diseases. Haematologica 82(3), 375–381 (1997).
  • Henze T, Rieckmann P, Toyka KV; Multiple Sclerosis Therapy Consensus Group of the German Multiple Sclerosis Society. Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur. Neurol. 56(2), 78–105 (2006).
  • Kes VB, Zavoreo I, Seric V et al.; Croatian Society for Neurovascular Disorders of Croatian Medical Association; Croatian Society of Neurology of Croatian Medical Association; Referral Center for Demyelinating Diseases of the CNS. Recommendations for diagnosis and management of multiple sclerosis. Acta Clin. Croat. 51(1), 117–135 (2012).
  • Amato MP, Portaccio E. Management options in multiple sclerosis-associated fatigue. Expert Opin. Pharmacother. 13(2), 207–216 (2012).
  • Sullivan AB, Scheman J, Venesy D, Davin S. The role of exercise and types of exercise in the rehabilitation of chronic pain: specific or nonspecific benefits. Curr. Pain Headache Rep. 16(2), 153–161 (2012).
  • Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J. Neurol. Neurosurg. Psychiatr. 56(10), 1062–1065 (1993).
  • Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch. Neurol. 47(7), 738–742 (1990).
  • Paavilainen T, Kurki T, Parkkola R et al. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. Eur. J. Neurol. 14(11), 1216–1221 (2007).
  • Abramsky O. Pregnancy and multiple sclerosis. Ann. Neurol. 36, S38–S41 (1994).
  • Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 9(7), 705–713 (1999).
  • Birk K, Smeltzer SC, Rudick R. Pregnancy and multiple sclerosis. Semin. Neurol. 8(3), 205–213 (1988).
  • Boyd AS, Morris LF, Phillips CM et al. Psoriasis and pregnancy: hormone and immune system interaction. Int. J. Dermatol. 35, 169–172 (1996).
  • Da Silva JA, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin. Rheumatol. 11(2), 189–194 (1992).
  • Damek DM, Shuster EA. Pregnancy and multiple sclerosis. Mayo Clin. Proc. 72(10), 977–989 (1997).
  • Davies TF. The thyroid immunology of the postpartum period. Thyroid 9(7), 675–684 (1999).
  • Dunna SF, Finlay AY. Psoriasis: improvement during and worsening after pregnancy. Br. J. Dermatol. 120(4), 584 (1989).
  • McNeill ME. Multiple pregnancy-induced remissions of psoriatic arthritis: case report. Am. J. Obstet. Gynecol. 159(4), 896–897 (1988).
  • Muller AF, Verhoeff A, Mantel MJ, Berghout A. Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertil. Steril. 71(1), 30–34 (1999).
  • Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Remission of rheumatoid arthritis during pregnancy and maternal–fetal class II alloantigen disparity. Am. J. Reprod. Immunol. 28(3–4), 226–227 (1992).
  • Ostensen M. The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am. J. Reprod. Immunol. 28(3–4), 235–237 (1992).
  • Park BS, Youn JI. Factors influencing psoriasis: an analysis based upon the extent of involvement and clinical type. J. Dermatol. 25(2), 97–102 (1998).
  • Terry AJ, Hague WM. Postpartum thyroiditis. Semin. Perinatol. 22(6), 497–502 (1998).
  • van Walderveen MA, Tas MW, Barkhof F et al. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 44(2), 327–329 (1994).
  • Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science 283(5406), 1277–1278 (1999).
  • Jungers P, Dougados M, Pélissier C et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch. Intern. Med. 142(4), 771–776 (1982).
  • Huizinga TW, van der Linden MW, Deneys-Laporte V, Breedveld FC. Interleukin-10 as an explanation for pregnancy-induced flare in systemic lupus erythematosus and remission in rheumatoid arthritis. Rheumatology (Oxf.) 38(6), 496–498 (1999).
  • Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151(9), 4562–4573 (1993).
  • Sacks GP, Clover LM, Bainbridge DR, Redman CW, Sargent IL. Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta 22(6), 550–559 (2001).
  • Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14(7), 353–356 (1993).
  • Dudley DJ, Chen CL, Mitchell MD, Daynes RA, Araneo BA. Adaptive immune responses during murine pregnancy: pregnancy-induced regulation of lymphokine production by activated T lymphocytes. Am. J. Obstet. Gynecol. 168(4), 1155–1163 (1993).
  • Elenkov IJ, Wilder RL, Bakalov VK et al. IL-12, TNF-α, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab. 86(10), 4933–4938 (2001).
  • Fabris N, Piantanelli L, Muzzioli M. Differential effect of pregnancy or gestagens on humoral and cell-mediated immunity. Clin. Exp. Immunol. 28, 306 (1977).
  • Hill JA, Polgar K, Anderson DJ. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273(24), 1933–1936 (1995).
  • Formby B. Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol. Metab. Clin. North Am. 24(1), 187–205 (1995).
  • Krishnan L, Guilbert LJ, Russell AS et al. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-γ response and increased production of T helper 2 cytokines. J. Immunol. 156(2), 644–652 (1996).
  • Marzi M, Vigano A, Trabattoni D et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106(1), 127–133 (1996).
  • Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 171(11), 6267–6274 (2003).
  • Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today 18(10), 478–482 (1997).
  • Sicotte NL, Liva SM, Klutch R et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 52(4), 421–428 (2002).
  • Gold SM, Sasidhar MV, Morales LB et al. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα). Lab. Invest. 89(10), 1076–1083 (2009).
  • Riskind PN, Massacesi L, Doolittle TH, Hauser SL. The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann. Neurol. 29(5), 542–547 (1991).
  • Weigent DA, Carr DJ, Blalock JE. Bidirectional communication between the neuroendocrine and immune systems. Common hormones and hormone receptors. Ann. N. Y. Acad. Sci. 579, 17–27 (1990).
  • Weinshenker BG, Hader W, Carriere W, Baskerville J, Ebers GC. The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 39(11), 1438–1440 (1989).
  • Duquette P, Girard M. Hormonal factors in susceptibility to multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 6(2), 195–201 (1993).
  • Verdru P, Theys P, D’Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin. Neurol. Neurosurg. 96(1), 38–41 (1994).
  • Achiron A, Rotstein Z, Noy S, Mashiach S, Dulitzky M, Achiron R. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study. J. Neurol. 243(1), 25–28 (1996).
  • Haas J. High dose IVIG in the postpartum period for prevention of exacerbations in MS. Mult. Scler. 6(Suppl. 2), S18–S20 (2000).
  • Orvieto R, Achiron R, Rotstein Z, Noy S, Bar-Hava I, Achiron A. Pregnancy and multiple sclerosis: a 2-year experience. Eur. J. Obstet. Gynecol. Reprod. Biol. 82(2), 191–194 (1999).
  • Haas J, Hommes OR. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult. Scler. 13(7), 900–908 (2007).
  • Durufle A, Nicolas B, Petrilli S et al. Effects of pregnancy and childbirth on the incidence of urinary disorders in multiple sclerosis. Clin. Exp. Obstet. Gynecol. 33(4), 215–218 (2006).
  • Dickerman RD, Schneider SJ, Stevens QE, Matarese NM, Decker RE. Prophylaxis to avert exacerbation/relapse of multiple sclerosis in affected patients undergoing surgery. Surgical observations and recommendations. J. Neurosurg. Sci. 48(3), 135–137; discussion 137 (2004).
  • Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J. Neurol. Sci. 129(1), 1–8 (1995).
  • Koseoglu BF, Gokkaya NK, Ergun U, Inan L, Yesiltepe E. Cardiopulmonary and metabolic functions, aerobic capacity, fatigue and quality of life in patients with multiple sclerosis. Acta Neurol. Scand. 114(4), 261–267 (2006).
  • Dorotta IR, Schubert A. Multiple sclerosis and anesthetic implications. Curr. Opin. Anaesthesiol. 15(3), 365–370 (2002).
  • Kuczkowski KM. Labor analgesia for the parturient with neurological disease: what does an obstetrician need to know? Arch. Gynecol. Obstet. 274(1), 41–46 (2006).
  • Vercauteren M, Heytens L. Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe? Acta Anaesthesiol. Scand. 51(7), 831–838 (2007).
  • Kulkarni LM, Sanikop C, Shilpa H, Vinayan A. Anaesthetic management in a patient with multiple sclerosis. Indian J. Anaesth. 55(1), 64–67 (2011).
  • Schneider KM. AANA Journal course: update for nurse anesthetists–an overview of multiple sclerosis and implications for anesthesia. AANA J. 73(3), 217–224 (2005).
  • Rieckmann P, Traboulsee A, Devonshire V, Oger J. Escalating immunotherapy of multiple sclerosis. Ther. Adv. Neurol. Disord. 1(3), 181–192 (2008).
  • Bódis L, Szupera Z, Pierantozzi M et al. Neurological complications of pregnancy. J. Neurol. Sci. 153(2), 279–293 (1998).
  • Walther EU, Hohlfeld R. Multiple sclerosis: side effects of interferon β therapy and their management. Neurology 53(8), 1622–1627 (1999).
  • Hughes SE, Thompson H, Gray OM; ECTRIMS. Interferon therapy and the effect on pregnancy outcomes in MS: time to take another look? Presented at: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis. Amsterdam, The Netherlands, 19–22 October 2011.
  • Coyle PK, Johnson K, Pardo L et al. Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone 1). Presented at: The 55th Annual Meeting of the American Academy of Neurology. HI, USA, 29 March–5 April 2003.
  • Fragoso YD, Finkelsztejn A, Kaimen-Maciel DR et al. Long term use of glatiramer acetate by 11 pregnant women with MS: a retrospective, multicentre case series. CNS Drugs 24(11), 969–976 (2010).
  • ECTRIMS. Fragoso YD, Aguayo-Arcelis A et al. The effects of long term exposure to DMDs during pregnancy Clin. Neurol. Neurosurg. 115(2), 154–159 (2013).
  • Niino M, Bodner C, Simard ML et al. Natalizumab effects on immune cell responses in multiple sclerosis. Ann. Neurol. 59(5), 748–754 (2006).
  • Ransohoff RM. Natalizumab for multiple sclerosis. N. Engl. J. Med. 356(25), 2622–2629 (2007).
  • Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult. Scler. 17(8), 958–963 (2011).
  • Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. Pregnancy outcome following cancer chemotherapy. Am. J. Med. 69(6), 828–832 (1980).
  • Murray CL, Reichert JA, Anderson J, Twiggs LB. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report. JAMA 252(18), 2607–2608 (1984).
  • Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch. Intern. Med. 160(5), 610–619 (2000).
  • Milunsky A, Graef JW, Gaynor MF Jr. Methotrexate-induced congenital malformations. J. Pediatr. 72(6), 790–795 (1968).
  • Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am. J. Med. 88(6), 589–592 (1990).
  • Cohen JA, Barkhof F, Comi G et al.; TRANSFORMS Study Group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362(5), 402–415 (2010).
  • Kappos L, Radue EW, O’Connor P et al.; FREEDOMS Study Group. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362(5), 387–401 (2010).
  • O’Connor P, Li D, Freedman M et al. Oral teriflunomide is effective and well tolerated in multiple sclerosis with relapses: results of an open-label 144-week extension study. Presented at: 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Madrid, Spain, 28 September 2006 (Poster 379).
  • O’Connor P, Wolinsky J, Confavreux C et al. A placebo controlled Phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis: clinical efficacy and safety outcomes [abstract]. Mult. Scler. 16, S23–S79 (2010).
  • Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 259(23), 3441–3443 (1988).
  • Whitaker JN. Effects of pregnancy and delivery on disease activity in multiple sclerosis. N. Engl. J. Med. 339(5), 339–340 (1998).
  • Langer-Gould A, Huang SM, Gupta R et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch. Neurol. 66(8), 958–963 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.